Background: With breast implant–associated anaplastic large cell lymphoma (BIA-ALCL)
now accepted as a unique (iatrogenic) subtype of ALCL directly associated with textured …

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a recently
recognized non-Hodgkin lymphoma of T-cell origin. Despite the low incidence of this new …

Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) is an uncommon type
of T-cell lymphoma. Although with a low incidence, the epidemiological data raised the …

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is an uncommon T-
cell, CD-30+/ALK lymphoma. Late (9 years) periprosthetic fluid (seroma) is the most …

The oncogenic events involved in breast implant–associated anaplastic large cell lymphoma
(BI-ALCL) remain elusive. To clarify this point, we have characterized the genomic …

PURPOSE To provide guidelines for the accurate pathologic diagnosis of breast implant–
associated anaplastic large cell lymphoma (BIA-ALCL), the preoperative evaluation of the …

Simple Summary Anaplastic large cell lymphoma is a rare type of disease that occurs
throughout the world and has four subtypes. A summary and comparison of these subtypes …

Breast implant–associated anaplastic large cell lymphoma (BIA-ALCL) is a very rare type of
T-cell lymphoma that is uniquely caused by a single environmental stimulus. Here, we …

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a CD30-positive,
anaplastic lymphoma kinase-negative T-cell lymphoma. Where implant history is known, all …

Simple Summary ALK-anaplastic large cell lymphoma (ALK-ALCL) is a rare subtype of
CD30+ large T-cell lymphoma that typically affects older adults and has a poor prognosis …